Artificial Intelligence in Drug Discovery – Data, Translation, and Start-Ups
Keynote Speaker
Professor Andreas Bender – Professor for Machine Learning in Medicine, Khalifa University; biotech entrepreneur and former Professor at the University of Cambridge.
Seminar Overview
Artificial Intelligence has been applied to drug discovery with varying levels of success. In this seminar, Professor Bender will highlight:
The unique characteristics of life sciences data and why they differ from speech or image data.
The challenges of translating AI models into in vivo, clinically relevant outcomes – the ultimate goal of drug discovery.
Areas where predictive models show clear value, such as physicochemical property prediction and drug repurposing.
Lessons learned from his experience co-founding and leading three AI/biotech companies, several of which now have compounds in clinical phases.